The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Landau Jeffrey B since 2022.
This trader's CIK number is 1918615.
At the time of last reporting, Landau Jeffrey B was the Chief Business Officer of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CTMX | 0 | $0 | 4,181 | $5,138 | 11,250 | $0 |
| 2023 | CTMX | 0 | $0 | 9,673 | $13,906 | 0 | $0 |
| 2022 | CTMX | 0 | $0 | 4,206 | $5,980 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-20 | CTMX | Sale | 4,181 | 1.23 | 5,138 |
| 2024-08-20 | CTMX | Option Ex | 11,250 | .00 | 0 |
| 2023-12-20 | CTMX | Sale | 4,077 | 1.38 | 5,630 |
| 2023-09-22 | CTMX | Sale | 4,119 | 1.30 | 5,354 |
| 2023-03-16 | CTMX | Sale | 1,477 | 1.98 | 2,922 |
| 2022-07-20 | CTMX | Sale | 4,206 | 1.42 | 5,980 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Landau Jeffrey B (Chief Business Officer of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.